Skip to content

Pasadena Star News

64°F
Friday, May 1st 2026

e-Edition

Trending:

Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biolargo Inc (OP:BLGO)

0.0875 +0.0035 (+4.17%)
Streaming Delayed Price Updated: 9:44 AM EDT, Sep 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biolargo Inc

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Gabelli To Host 4th Annual PFAS Symposium
From Gabelli Funds
Via GlobeNewswire
News headline image
BioLargo Canada and Tu Nipi Form Indigenous-Led Partnership to Treat Oil Sands Process Water and More
Partnership backed by a conditional grant commitment from Emissions Reduction Alberta to in support of $4.6 CAD million project, with commercial trials already underway in northern Alberta 
From BioLargo, Inc
Via ACCESS Newswire
News headline image
BioLargo Townhall and Q2 2026 Earnings Results Webcast and Conference Call on Thursday, September 10th, 2026 - 4:00 PM Eastern Time
From BioLargo, Inc
Via ACCESS Newswire
News headline image
BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution
From BioLargo, Inc
Via ACCESS Newswire
News headline image
BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026
From BioLargo, Inc.
Via ACCESS Newswire
News headline image
BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York
From BioLargo, Inc
Via ACCESS Newswire
News headline image
Gabelli To Host 4th Annual PFAS Symposium
From Gabelli Funds
Via GlobeNewswire
News headline image
BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%
From BioLargo, Inc
Via ACCESS Newswire
News headline image
BioLargo's Lake Stockholm AEC Installation passes six months of PFAS remediation Topping Two Million Gallons
From BioLargo, Inc.
Via ACCESS Newswire
News headline image
BioLargo Joins New Jersey Institute of Technology-Led PFAS Consortium; President Tonya Chandler Appointed to Board of Directors
From BioLargo, Inc
Via ACCESS Newswire
News headline image
BioLargo Equipment Solutions & Technologies' "PFAS Lady" to Teach PFAS 101 at 41st Annual Tri-State Seminar
From BioLargo, Inc
Via ACCESS Newswire
News headline image
BioLargo PFAS Treatment Technology Featured in The Disruptive Quarterly
From BioLargo, Inc
Via ACCESS Newswire
News headline image
BioLargo Relaunching CupriDyne(R)-Based Consumer Products - Back by Popular Demand and Generated More than $125 Million in Pet-Care Sales
From BioLargo, Inc
Via ACCESS Newswire
News headline image
BioLargo Engineering Unit Awarded $1.4 Million in U.S. Air Force Environmental Contract Renewals
From BioLargo, Inc
Via ACCESS Newswire
News headline image
BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent Markets
Via ACCESS Newswire
News headline image
BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment Technology
Via ACCESS Newswire
News headline image
BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026
Via ACCESS Newswire
News headline image
BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery
Via ACCESS Newswire
News headline image
BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum
Via ACCESS Newswire
News headline image
BioLargo Reports Annual 2025 Operating and Financial Results
Via ACCESS Newswire
News headline image
BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time
Via ACCESS Newswire
News headline image
BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium
Via ACCESS Newswire
News headline image
BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation Solution
Via ACCESS Newswire
News headline image
BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm EST
Via ACCESS Newswire
News headline image
BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical Innovation
Via ACCESS Newswire
News headline image
BioLargo Subsidiary BEST Featured in Chemical Engineering Magazine for PFAS Breakthrough
Via ACCESS Newswire
News headline image
BioLargo Reports Q3 2025 Operating and Financial Results
Via ACCESS Newswire
News headline image
BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
Via ACCESS Newswire
News headline image
BioLargo Subsidiary Clyra Medical Technologies Forms Strategic Alliance with Advanced Solution to Launch ViaCLYR(TM) Wound Irrigation Solution Nationwide
Via ACCESS Newswire
News headline image
BioLargo Files Federal Lawsuit Against Pooph Inc.
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.